Cargando…
Disruption of the pentraxin 3/CD44 interaction as an efficient therapy for triple‐negative breast cancers
Due to the heterogeneity and high frequency of genome mutations in cancer cells, targeting vital protumour factors found in stromal cells in the tumour microenvironment may represent an ideal strategy in cancer therapy. However, the regulation and mechanisms of potential targetable therapeutic candi...
Autores principales: | Hsiao, Yu‐Wei, Chi, Jhih‐Ying, Li, Chien‐Feng, Chen, Lei‐Yi, Chen, Yi‐Ting, Liang, Hsin‐Yin, Lo, Yu‐Chih, Hong, Jhen‐Yi, Chuu, Chin‐Pin, Hung, Liang‐Yi, Du, Jyun‐Yi, Chang, Wen‐Chang, Wang, Ju‐Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797470/ https://www.ncbi.nlm.nih.gov/pubmed/35090088 http://dx.doi.org/10.1002/ctm2.724 |
Ejemplares similares
-
Blockade of the pentraxin 3/CD44 interaction attenuates lung injury‐induced fibrosis
por: Chi, Jhih‐Ying, et al.
Publicado: (2022) -
Pentraxin 3 Facilitates Shrimp-Allergic Responses in IgE-Activated Mast Cells
por: Du, Jyun-Yi, et al.
Publicado: (2022) -
Synchronous vascular endothelial growth factor protein profiles in both tissue and serum identify metastasis and poor survival in colorectal cancer
por: Yeh, Chien-Chih, et al.
Publicado: (2019) -
Synchronous triple carcinoma of the colon and rectum
por: Yeh, Chien-Chih, et al.
Publicado: (2013) -
Impact of pentraxin 3 genetic variants on uterine cervical cancer clinicopathologic characteristics
por: Sun, Yi-Hung, et al.
Publicado: (2021)